Warner Pharmaceuticals announced that it recently received the “Drug Registration Certificate” for isoprenaline hydrochloride injections approved and issued by the State Drug Administration. The specifications are 1 ml: 0.2 mg, 5 ml: 1 mg, and the registration classification is 3 types of chemicals. This injection is used to treat cardiogenic or infectious shock, etc., and is deemed to have passed the consistency evaluation. Its achievements have enriched the company's formulation product range and optimized the product structure, but it will not have a significant impact on recent performance. Future sales are affected by factors such as policies and markets, and are uncertain.

Warner Pharmaceuticals announced that it recently received the “Drug Registration Certificate” for isoprenaline hydrochloride injections approved and issued by the State Drug Administration. The specifications are 1 ml: 0.2 mg, 5 ml: 1 mg, and the registration classification is 3 types of chemicals. This injection is used to treat cardiogenic or infectious shock, etc., and is deemed to have passed the consistency evaluation. Its achievements have enriched the company's formulation product range and optimized the product structure, but it will not have a significant impact on recent performance. Future sales are affected by factors such as policies and markets, and are uncertain.